GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Johnson & Johnson (BSP:JNJB34) » Definitions » E10

Johnson & Johnson (BSP:JNJB34) E10 : R$2.98 (As of Dec. 2024)


View and export this data going back to 2011. Start your Free Trial

What is Johnson & Johnson E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Johnson & Johnson's adjusted earnings per share data for the three months ended in Dec. 2024 was R$0.573. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is R$2.98 for the trailing ten years ended in Dec. 2024.

During the past 12 months, Johnson & Johnson's average E10 Growth Rate was 0.40% per year. During the past 3 years, the average E10 Growth Rate was 8.20% per year. During the past 5 years, the average E10 Growth Rate was 9.30% per year. During the past 10 years, the average E10 Growth Rate was 4.80% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Johnson & Johnson was 16.60% per year. The lowest was -0.10% per year. And the median was 11.45% per year.

As of today (2025-03-27), Johnson & Johnson's current stock price is R$61.82. Johnson & Johnson's E10 for the quarter that ended in Dec. 2024 was R$2.98. Johnson & Johnson's Shiller PE Ratio of today is 20.74.

During the past 13 years, the highest Shiller PE Ratio of Johnson & Johnson was 33.32. The lowest was 19.28. And the median was 26.39.


Johnson & Johnson E10 Historical Data

The historical data trend for Johnson & Johnson's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Johnson & Johnson E10 Chart

Johnson & Johnson Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.72 2.15 2.21 2.32 2.98

Johnson & Johnson Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2.32 2.44 2.73 2.62 2.98

Competitive Comparison of Johnson & Johnson's E10

For the Drug Manufacturers - General subindustry, Johnson & Johnson's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Johnson & Johnson's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Johnson & Johnson's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Johnson & Johnson's Shiller PE Ratio falls into.


';

Johnson & Johnson E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Johnson & Johnson's adjusted earnings per share data for the three months ended in Dec. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2024 (Change)*Current CPI (Dec. 2024)
=0.573/133.1571*133.1571
=0.573

Current CPI (Dec. 2024) = 133.1571.

Johnson & Johnson Quarterly Data

per share eps CPI Adj_EPS
201503 0.320 99.621 0.428
201506 0.334 100.684 0.442
201509 0.312 100.392 0.414
201512 0.298 99.792 0.398
201603 0.392 100.470 0.520
201606 0.326 101.688 0.427
201609 0.332 101.861 0.434
201612 0.309 101.863 0.404
201703 0.336 102.862 0.435
201706 0.308 103.349 0.397
201709 0.286 104.136 0.366
201712 -0.876 104.011 -1.121
201803 0.350 105.290 0.443
201806 0.365 106.317 0.457
201809 0.394 106.507 0.493
201812 0.290 105.998 0.364
201903 0.356 107.251 0.442
201906 0.535 108.070 0.659
201909 0.181 108.329 0.222
201912 0.410 108.420 0.504
202003 0.707 108.902 0.864
202006 0.470 108.767 0.575
202009 0.479 109.815 0.581
202012 0.223 109.897 0.270
202103 0.872 111.754 1.039
202106 0.788 114.631 0.915
202109 0.482 115.734 0.555
202112 0.667 117.630 0.755
202203 0.640 121.301 0.703
202206 0.606 125.017 0.645
202209 0.587 125.227 0.624
202212 0.465 125.222 0.494
202303 -0.010 127.348 -0.010
202306 0.634 128.729 0.656
202309 3.362 129.860 3.447
202312 0.546 129.419 0.562
202403 0.445 131.776 0.450
202406 0.693 132.554 0.696
202409 0.410 133.029 0.410
202412 0.573 133.157 0.573

Add all the adjusted EPS together and divide 10 will get our e10.


Johnson & Johnson  (BSP:JNJB34) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Johnson & Johnson's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=61.82/2.98
=20.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Johnson & Johnson was 33.32. The lowest was 19.28. And the median was 26.39.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Johnson & Johnson E10 Related Terms

Thank you for viewing the detailed overview of Johnson & Johnson's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Johnson & Johnson Business Description

Address
One Johnson & Johnson Plaza, New Brunswick, NJ, USA, 08933
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: pharmaceutical and medical devices. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. The drug division focuses on the following therapeutic areas: immunology, oncology, neurology, pulmonary, cardiology, and metabolic diseases. Geographically, just over half of total revenue is generated in the United States.

Johnson & Johnson Headlines

No Headlines